The largest database of trusted experimental protocols

8 protocols using ficoll cushion

1

Blood and PBMC Collection Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples were taken directly from the jugular vein into Venojet glass tubes, without anticoagulant on days 0 (naïve), 7, 21, 28, 42 (pre-challenge), 3, 5, 7, 11 and 13 (post-challenge) and allowed to clot overnight at 4°C. Serum was obtained by centrifugation at 3000 rpm for 10 minutes (min) at 4°C, aliquoted and stored at −80°C until use. PBMCs were obtained from total blood collected in EDTA and purified by Ficoll cushion (GE Healthcare) purification as described previously [28] (link).
+ Open protocol
+ Expand
2

Isolation and Culture of Human Monocyte-Derived Macrophages

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human monocyte-derived macrophages (hMDMs) were derived from human blood acquired via venipuncture from healthy donors following a Ohio State University Institutional Review Board approved protocol. Written informed consent was provided by study participants. The protocol followed published methods (Schlesinger et al., 1990 (link); Hoang et al., 2016 (link)). Briefly, peripheral blood mononuclear cells (PBMCs) were isolated from heparinized blood over a Ficoll cushion (GE Healthcare Bio-Science, Piscataway, NJ, United States). PBMCs were then cultured in sterile screw-cap Teflon wells in RPMI 1640 plus L-glutamine (Gibco-Life Technologies, Grand Island, NY, United States) with 20% autologous human serum at 37°C in a humidified incubator containing 5% CO2 for 5 days. Teflon wells were chilled on ice to recover the PBMCs, which were then re-suspended in RPMI 1640 with 10% autologous serum. Cells were then allowed to attach in 24-well or 6-well tissue culture plates for 2–3 h at 37°C in a humidified incubator with 5% CO2. After washing to remove the lymphocytes, hMDM monolayers were seeded at a density of approximately 2.0 × 105 cells/well for 24-well plates for infection studies.
+ Open protocol
+ Expand
3

PBMC Isolation and Serum Collection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral blood mononuclear cells (PBMCs) were obtained from total blood collected in EDTA directly from the jugular vein and purified by Ficoll cushion (GE Healthcare) purification as described previously (18 (link)). For serum collection, blood samples were taken into Venojet glass tubes, without anticoagulant on days 0 (naive), 7, 21, 28, and 42 (pre-challenge) and days 2, 4, 7, 9, 11, and 14 (post-challenge) and allowed to clot overnight at 4°C. On the next day, serum was obtained by centrifugation at 3,000 rpm for 10 min at 4°C, aliquoted, and stored at −80°C until use.
+ Open protocol
+ Expand
4

Peripheral Blood Mononuclear Cell Isolation for BTV Study

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral blood mononuclear cells (PBMCs) were obtained from 100 ml of total blood collected in EDTA from jugular vein at day 0 prior to infection and days 3, 7 and 15 post-BTV infection. The samples were purified using Ficoll cushion (GE Healthcare) purification method as described in (36 (link)). PBMCs were frozen as described in (36 (link)). When necessary, PBMCs were cultured in PBMC culture medium (RPMI supplemented with 10% FBS (Sigma), 4 mM L-glutamine, 10 mM HEPES, 1% 100X non-essential aminoacids, 1 mM sodium pyruvate, 100U/mL penicillin/100 μg/mL streptomycin and 50nM β-mercaptoethanol (all from Invitrogen)).
+ Open protocol
+ Expand
5

Peripheral Blood Mononuclear Cell Isolation for BTV Study

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral blood mononuclear cells (PBMCs) were obtained from 100 ml of total blood collected in EDTA from jugular vein at day 0 prior to infection and days 3, 7 and 15 post-BTV infection. The samples were purified using Ficoll cushion (GE Healthcare) purification method as described in (36 (link)). PBMCs were frozen as described in (36 (link)). When necessary, PBMCs were cultured in PBMC culture medium (RPMI supplemented with 10% FBS (Sigma), 4 mM L-glutamine, 10 mM HEPES, 1% 100X non-essential aminoacids, 1 mM sodium pyruvate, 100U/mL penicillin/100 μg/mL streptomycin and 50nM β-mercaptoethanol (all from Invitrogen)).
+ Open protocol
+ Expand
6

Isolation and Culture of hMDMs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Preparation of hMDMs and THP-1 cells was described previously57 ,58 . Human peripheral blood was obtained from healthy donors with written informed consent via venipuncture following a protocol approved by Nationwide Children’s Institutional Review Board. Peripheral mononuclear cells (PBMCs) were isolated from heparinized blood using a Ficoll cushion (GE Healthcare Bio-Science, Piscataway, NJ, USA). The PBMCs were then washed with RPMI 1640 plus L-glutamine (Gibco-Life Technologies, Grand Island, NY, USA). PBMCs were cultured in Teflon wells with RPMI 1640 plus L-glutamine containing 20% human AB serum (Sigma Aldrich, P2918) at 37°C for 5 days. hMDMs were recovered from Teflon wells and plated at 2×105 cells/well in a 24-well tissue culture plate in the presence of 10% human AB serum for 2 h at 37°C. Lymphocytes were then washed away leaving a hMDM monolayer. The hMDM monolayer was maintained in RPMI supplemented with 10% human AB serum for 4 days before used in Salmonella infection experiments. hMDMs and THP-1 infection with S. Typhimurium and Western blot analysis were performed as previously described59 . Macrophage cell lysates were collected at 4 h post-infection and subjected to Western blot for GNLY (R&D Systems Cat# AF3138-SP; 1:500 dilution), CCL20 (R&D Systems Cat# AF360-SP; 1:500), and/or actin (Abcam Cat# 179467; 1:1000) using 40 μg of total protein.
+ Open protocol
+ Expand
7

Isolation and Stimulation of Ovine PBMCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral blood mononuclear cells (PBMCs) were obtained by standard gradient centrifugation method. Briefly, blood collected in EDTA (6mM final concentration) was diluted 1:1 in PBS + 0.03% (w/v) EDTA and overlaid over a Ficoll cushion (GE Health-care Europe GmbH). Blood was centrifuged at 800 x g for 30 min at room temperature without brake, and the PBMCs present at the interface were transferred to a fresh tube and washed with PBS+0.03% (w/v) EDTA. 2–3 x 105 PBMCs/well were cultured in the presence of BEI-inactivated BTV-8 or negative controls for 5h at 37°C 5% CO2 in 96-well plates, in presence of 1 μg/ml of brefeldin-A (Sigma-Aldrich). Cells were harvested and stained with anti-ovine CD4-FITC and anti-ovine CD8-PE antibodies (Serotec). After permeabilisation, PBMCs were stained with anti-ovine IFN-γ-A647 antibody (Serotec). Cells were acquired on a BD FACSCalibur flow cytometer (Becton Dickinson and Co., Franklin Lakes, New Jersey, USA) and analyzed with FlowJo software (Tree Star Inc., San Francisco, CA, USA).
+ Open protocol
+ Expand
8

EBV Virus Production and B Cell Isolation

Check if the same lab product or an alternative is used in the 5 most similar protocols
EBV virus production was performed using a producer clone of EBV strain 2089 (bacterial artificial chromosome harboring GFP and EBV strain B95.8, a kind gift from Jeff Cohen, NIAID, NIH, USA). Virus stocks were titrated on Raji cells as previously reported and used at a multiplicity of infection (MOI) of 0.1 green Raji units for infecting primary B lymphocytes with an optimal virus dose (38 (link)). Buffy coats from three different donors were purified through a Ficoll cushion (GE Healthcare). Rosetting was performed with sheep blood (Thermo Fisher Scientific), and PBMCs were again purified through a Ficoll cushion. Last, PBMCs were treated with red blood cell (RBC) lysis buffer (BioLegend) and washed three times with phosphate-buffered saline (PBS) (Gibco). B cells sent for RNA sequencing were purified from buffy coats using MACSExpress Whole Blood B cell isolation kit (Miltenyi Biotec) following the manufacturer’s protocol. For virus infection, PBMCs were cultivated with each virus stock for 18 h. After replacement with fresh medium, the infected cells were seeded at an initial density of 5 × 105 cells per ml. Cyclosporine (1 μg/ml; Abcam) was added for the duration of the experiment to suppress T cell activation.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!